Robotic partial surgery
ProcedureRobotic partial surgery
NCT Number: NCT03292549
The purpose of the study is to set up the larger prospective study on robotic partial nephrectomy, to describe the characteristics of patients operated for kidney cancer by this surgical procedure and also to determine the modalities of hemostasis in this procedure.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
CHU Bordeaux, Bordeaux, France
The primary objective of the study is to describe the characteristics of patients operated for kidney cancer by a robotic partial nephrectomy in France (recruiting centers, patient profile, tumor characteristics).
Secondary Objective(s):
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
None
Robotic partial surgery
Time frame: From surgery until 1 year of follow up
Per and post-operative transfusion rates
Time frame: From surgery until 1 year of follow up
Medical or surgical complication rates
Time frame: From surgery until 1 year of follow up
Clavien's grading
Time frame: From surgery until 1 year of follow up
Urinary fistula rate
Time frame: From surgery until 1 year of follow up
Necessity for nephrectomy or re-exploration
Time frame: From surgery until 1 year of follow up
Length of hospital stay
Time frame: Follow-up during 12 months
Creatininemia
Time frame: Follow-up during 12 months
MDRD GFR
Time frame: At Surgery
Haemostasis procedure
Time frame: At Surgery
Haemostatic agent
University Hospital, Bordeaux
Other
RObotic PArtial Nephrectomy National Study (RoPaN Study)
Acronym: ROPAN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06955910
Behavior, Behavioral Symptoms
Padova, Italy/Padova, Italy
View Trial DetailsNCT03345563
Bladder Cancer, Colon Cancer
New Brunswick, New Jersey, United States
View Trial DetailsNCT00403169
Adenocarcinoma, Carcinoma
Cleveland, Ohio, United States
View Trial DetailsNCT04000880
Adnexal Diseases, Behavior
Birmingham, Alabama, United States
View Trial Details